Brk (h): 293T Lysate: sc-112582

Brk (h): 293T Lysate is derived from the 293T cell line, a human embryonic kidney cell line modified to express the SV40 large T antigen, enhancing its transfection efficiency and protein expression capabilities. This lysate is specifically enriched with human Breast tumor kinase (Brk), also known as Protein Tyrosine Kinase 6 (PTK6), a non-receptor tyrosine kinase implicated in regulating various cellular processes such as proliferation, differentiation, and migration. Brk functions by phosphorylating specific substrates involved in signal transduction pathways, influencing cellular responses to growth factors and other external signals. In research, Brk (h): 293T Lysate is utilized to investigate the molecular mechanisms by which Brk modulates signaling pathways and cellular behaviors. Researchers employ this lysate in Western blotting to detect and quantify Brk expression levels under different experimental conditions, providing insights into its regulation and activity. The lysate is also used in co-immunoprecipitation assays to identify and characterize protein-protein interactions involving Brk, helping to explain its role in signaling networks. Furthermore, functional assays using Brk (h): 293T Lysate are conducted to assess the kinase activity of Brk and its impact on downstream signaling pathways. These studies contribute to understanding how Brk influences cell proliferation, survival, and motility. The use of Brk (h): 293T Lysate allows for detailed investigations into the kinase's mechanisms of action and its involvement in cellular signal transduction, providing valuable insights into fundamental biological processes.